Literature DB >> 19863366

Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors.

Luis A García Rodríguez1, Mari-Ann Wallander, Laura Barreales Tolosa, Saga Johansson.   

Abstract

We evaluated the association of chronic obstructive pulmonary disease (COPD) with modifiable risk factors such as smoking and prescription medications, and investigated possible risk factors unique to patients who had never smoked. The UK General Practice Research Database was used to identify a cohort of patients with a first diagnosis of COPD (n = 1927) along with age- and sex-matched controls without COPD (n = 16 546). The incidence of COPD diagnoses and the risks associated with medication use, co-morbidities, and demographic factors, were estimated. The incidence of COPD was 2.6 per 1000 person-years (95% confidence interval [CI]: 2.5-2.7) among 40-89 year-olds. The risk significantly increased in current and former smokers (OR: 6.15 [95% CI: 5.41-7.00] and 3.45 [95% CI: 2.96-4.02]), respectively. The risk was significantly lower in former smokers than current smokers (OR: 0.61; 95% CI: 0.52-0.71). Current statin use was significantly associated with a reduced risk (OR: 0.45; 95% CI: 0.25-0.80). In never smokers, risk factors included advanced age and obesity. The risk in never smokers was more strongly related to paracetamol use (OR: 1.82; 95% CI: 1.33-2.49) than in current and former smokers (OR: 1.48; 95% CI: 1.18-1.86). In summary, COPD is associated with a range of cardiovascular and respiratory conditions and the risk is influenced by current and past medications. While the risk factors are similar in smokers and never smokers, some were unique to never smokers. Moreover, subjects who stopped smoking had a substantially lower COPD risk than those who continued smoking.

Entities:  

Mesh:

Year:  2009        PMID: 19863366     DOI: 10.1080/15412550903156325

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  15 in total

1.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Authors:  Martin Söderholm; Malin Inghammar; Bo Hedblad; Arne Egesten; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2015-12-28       Impact factor: 8.082

Review 2.  Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures.

Authors:  David J McCulley; Erik A Jensen; Jennifer M S Sucre; Sarah McKenna; Laura G Sherlock; Evgenia Dobrinskikh; Clyde J Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-03       Impact factor: 6.011

3.  Obstructive pulmonary disease in old age among individuals born preterm.

Authors:  Eva Berggren Broström; Olof Akre; Miriam Katz-Salamon; David Jaraj; Magnus Kaijser
Journal:  Eur J Epidemiol       Date:  2013-01-23       Impact factor: 8.082

4.  Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease.

Authors:  Rihong Zhai; Xiaojin Yu; Yongyue Wei; Li Su; David C Christiani
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

5.  Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease.

Authors:  Francisco García-Rio; Joan B Soriano; Marc Miravitlles; Luis Muñoz; Enric Duran-Tauleria; Guadalupe Sánchez; Victor Sobradillo; Julio Ancochea
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort.

Authors:  Ah Young Leem; Boram Park; Young Sam Kim; Ji Ye Jung; Sungho Won
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-05

Review 7.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20

8.  Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.

Authors:  Eirini Mitsiki; Eleni Bania; Christos Varounis; Konstantinos I Gourgoulianis; Evangelos C Alexopoulos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-20

Review 9.  Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

Authors:  Ana Filipa Macedo; Fiona Claire Taylor; Juan P Casas; Alma Adler; David Prieto-Merino; Shah Ebrahim
Journal:  BMC Med       Date:  2014-03-22       Impact factor: 8.775

10.  Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.

Authors:  Natalie Terzikhan; Katia M C Verhamme; Albert Hofman; Bruno H Stricker; Guy G Brusselle; Lies Lahousse
Journal:  Eur J Epidemiol       Date:  2016-03-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.